DAOBOOST Trademark

Trademark Overview


On Wednesday, December 6, 2023, a trademark application was filed for DAOBOOST with the United States Patent and Trademark Office. The USPTO has given the DAOBOOST trademark a serial number of 98302132. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 10, 2026. This trademark is owned by STADA Arzneimittel AG. The DAOBOOST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; sanitary preparations for medical purposes featuring diamine oxidase enzymes; biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; chemical reagents for medical purposes containing diamine oxidase enzymes; nutritional additives for medical purposes for use in foods and dietary supplements for human co...
daoboost

General Information


Serial Number98302132
Word MarkDAOBOOST
Filing DateWednesday, December 6, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; sanitary preparations for medical purposes featuring diamine oxidase enzymes; biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; chemical reagents for medical purposes containing diamine oxidase enzymes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, containing diamine oxidase enzymes; nutritional additives to foodstuffs for animals for medical purposes containing diamine oxidase enzymes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSTADA Arzneimittel AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBad Vilbel 61118
DE

Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBad Vilbel 61118
DE

Trademark Events


Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Monday, March 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Tuesday, June 25, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 25, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 7, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 13, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 13, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 29, 2025SOU TEAS EXTENSION RECEIVED
Monday, December 29, 2025SOU EXTENSION 1 FILED
Monday, December 29, 2025SOU EXTENSION 1 GRANTED
Tuesday, December 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 10, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, June 10, 2026SOU EXTENSION 2 FILED
Wednesday, June 10, 2026SOU EXTENSION 2 GRANTED
Thursday, June 11, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED